ROCKVILLE, Md., Feb. 25,
2025 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq:
RGNX) today announced it will participate in the following investor
conferences:
TD Cowen's 45th Annual Health Care
Conference
Fireside Chat: Wednesday, March 5 at 1:10pm ET
Location: Boston, MA
Leerink Partners Global Healthcare
Conference
Fireside Chat: Tuesday, March 11 at 9:20am ET
Location: Miami, FL
Barclays 27th Annual Global Healthcare
Conference
Fireside Chat: Wednesday, March 12 at 3:30pm ET
Location: Miami, FL
UBS Virtual CNS Day
Fireside Chat: Monday, March 17 at 10:00am ET
Location: Virtual
RBC Inaugural Virtual Ophthalmology
Conference
Fireside Chat: April 3 at 8:15am
ET
Location: Virtual
Live webcasts of select fireside chats can be accessed in the
Investors section of REGENXBIO's website at www.regenxbio.com. An
archived replay of the webcast will be available for approximately
30 days following the presentation.
ABOUT REGENXBIO Inc.
REGENXBIO is a leading
clinical-stage biotechnology company seeking to improve lives
through the curative potential of gene therapy. Since its founding
in 2009, REGENXBIO has pioneered the development of AAV
Therapeutics, an innovative class of gene therapy
medicines. REGENXBIO is advancing a pipeline of AAV
Therapeutics for rare and retinal diseases, including RGX-202 for
the treatment of Duchenne, ABBV-RGX-314 for the treatment of wet
AMD and diabetic retinopathy, being developed in collaboration with
AbbVie, and RGX-121 for the treatment of MPS II. Thousands of
patients have been treated with REGENXBIO's AAV
Therapeutic platform, including Novartis'
Zolgensma® for children with spinal muscular
atrophy. Designed to be one-time treatments, AAV Therapeutics have
the potential to change the way healthcare is delivered for
millions of people. For more information, please visit
WWW.REGENXBIO.COM.
Contacts:
Dana Cormack
Corporate Communications
dcormack@regenxbio.com
Investors:
George E. MacDougall
Investor Relations
IR@regenxbio.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/regenxbio-to-participate-in-upcoming-investor-conferences-302385213.html
SOURCE REGENXBIO Inc.
